bf/NASDAQ:CNSP_icon.jpeg

COM:CNSPHARMA

CNS Pharmaceuticals, Inc.

  • Stock

USD

Last Close

0.13

22/11 21:00

Market Cap

1.52M

Beta: -

Volume Today

194.47K

Avg: -

  • name

    CNS Pharmaceuticals, Inc.
  • homepage url

    www.cnspharma.com
  • country

    USUnited States
  • linkedin url

    cnspharma
  • crunchbase url

    cns-pharmaceutical
  • employee count

    3
  • sector

    Healthcare
  • industry

    Biotechnology
  • monthly webtraffic

    654
  • monthly webtraffic growth

    48.64%
  • stage

    Post-IPO Equity
  • raised capital

    3M

Description

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with H...Show More

peer of